Federal Register
Notice: FDA is amending the 2/1 notice of a 3/22 meeting of the Pediatric Advisory Committee to change the starting time to 7:30 a.m. and include in the agenda a hearing and discussion on cardiovascular adverse events possibly related to ADHD medications. Contact Jan N. Johannessen, (301) 827-6687. To view this notice, click here.